HOOKIPA Pharma Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
HOOKIPA Pharma Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2022 to Q3 2024.
  • HOOKIPA Pharma Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $939K, a 63.6% increase year-over-year.
  • HOOKIPA Pharma Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $1.57M.
  • HOOKIPA Pharma Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.35M, a 53.5% decline from 2022.
  • HOOKIPA Pharma Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.04M, a 34% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.57M $939K +$365K +63.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $1.2M $459K -$237K -34.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.44M -$249K -$907K -138% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.35M $417K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-22
Q3 2023 $574K -$466K -44.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $696K -$685K -49.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $658K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 $1.04M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.38M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.